Hubei Yuancheng Saichuang Technology Co.,Ltd.
Products
Contact Us
  • Contact Person : Ms. Silvia Liu
  • Company Name : Hubei Yuancheng Saichuang Technology Co.,Ltd.
  • Tel : 86-027-50756101
  • Fax : 86-027-68886696
  • Address : Hubei,Wuhan,Zhongshan
  • Country/Region : China
  • Zip : 430064

Furazabol

Furazabol
Product Detailed
Related Categories:Healthcare Supplies
Product Details Basic Info. Model NO.:CAS: 1239-29-8 Assay:98% Molecular Formula:C20h30n2o2 Molecular Weight:330.46 Appearance:White Crystalline Powder Einecs:214-983-0 Export Markets:Global Additional Info. Packing:Foil Bag or Tin Standard:USP/EP Origin:China HS Code:2937900090 Production Capacity:5000kg/Year Product Description Furazabol THP Alias: 17 -hydroxy-5 -androstano-[2, 3-c]furazan 17-THP ether; 5A-androstano(2, 3-c) furazan-17b-tetrahydropyranol ether; Dh245; Frazalon; Miotolon CAS: 1239-29-8 EINECS: 214-983-0 Molecular Formula: C20H30N2O2 Molecular Weight: 330.46 Molecular Structure: Properties: White crystalline powder, odorless, tasteless, does not dissolve in water. Usage: Treatment of hyperlipidemia and atherosclerosis. It have the ability to regulate blood lipid, cholesterol in the liver can promote the decomposition of acid excreted, has the effect of lowering cholesterol strong; Can inhibit fatty acid release from adipose tissue into the liver, reduce the free fatty acid content of the liver, liver triglyceride decreased, thereby reducing the level of triglycerides in the blood. Synthesis and metabolism, promoting and inhibition of protein metabolism, increase appetite, enhance physical fitness, promote growth and development and promoting tissue regeneration. Our advantages: 1. Best prices with satisfied quality. 2. Rich experienced in delivering the parcels to you. 3. Enough stock ensure the prompt delivery time. 4. Good after-sales service. 5. Package will be reshipped if sent failed. 6. Specials are possible when the order is big enough. Skype:silvialiu Email Address:[email protected] http//www.raw-steroid-powder.com


Copyright Notice @ 2008-2022 ECBAY Limited and/or its subsidiaries and licensors. All rights reserved.